slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 39,961-39,990
Pages 2,019
Rows per page 30
Component
39,961-39,990 of 60,568
05
The table uses a waterfall-style logic to explain the variance between two periods.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
16
The table displays GAAP financial metrics in millions of dollars, comparing Q1 2023 to Q1 2022 with percentage changes.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations 1 hit
17
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations 1 hit
18
The table includes a footnote clarifying the adjusted basis for specific segments.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations 1 hit
05
The chart illustrates the 'valley of death' in drug development, highlighting the low probability of success (POS) and the long timeline to commercialization.AbCellera | Investor Presentation Deck | 20 slides · AbCellera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
13
The slide highlights a new undisclosed molecule in Phase 1.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations 1 hit
06
Includes a visual representation of debt maturity and a callout regarding interest rate hedging.Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
08
Includes footnotes (1) through (9) referenced in the table rows.Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · Appendix1 hit
10
Includes footnotes referencing specific adjustments (10-13).Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · Appendix1 hit
11
Advantage Solutions | Results Presentation Deck | 13 slidesAdvantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · Appendix1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents clinical trial safety data comparing Pegzilarginase to a placebo group.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
23
The slide presents a standard quarterly financial comparison (P&L summary) and balance sheet highlights.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
26
The slide uses a Kaplan-Meier survival curve and a comparative table to illustrate the severity of the disease.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
30
The table displays mean/SD, range, and counts/percentages for Pegzilarginase (n=21), Placebo (n=11), and Overall (N=32).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
31
Data includes Plasma Arginine, GMFCS level, GMFM-E, and 2MWT metrics.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
33
Includes both continuous mean change data and categorical responder analysis.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
34
Includes a study design timeline at the bottom right and MCID reference lines on the GMFM-E chart.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
37
The slide highlights clinical response in specific patients, emphasizing normalization of mobility metrics.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
10
Aeva | Results Presentation Deck | 11 slidesAeva | Results Presentation Deck | 11 slides · Aeva
Conference presentation Investor relations Beat · Satisfaction1 hit
04
Allbirds | Investor Presentation Deck | 13 slidesAllbirds | Investor Presentation Deck | 13 slides · Allbirds
Conference presentation Investor relations Beat · Need1 hit
10
Includes MSCI ESG rating at the bottom.Allbirds | Investor Presentation Deck | 13 slides · Allbirds
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
13
Allbirds | Investor Presentation Deck | 13 slidesAllbirds | Investor Presentation Deck | 13 slides · Allbirds
Conference presentation Investor relations 1 hit
16
The table provides a bridge between statutory loss and non-IFRS metrics like Operational EBITDA and Free Cash Flow.Allego | Results Presentation Deck | 17 slides · Allego
Conference presentation Investor relations 1 hit
05
The slide serves as a justification for board composition by highlighting relevant professional experience of specific directors.Amazon | Shareholder Engagement Presentation Deck | 40 slides · Amazon
Shareholder letter Investor relations Beat · Problem1 hit
11
The slide uses a standard proxy statement format to justify management's position on specific voting items.Amazon | Shareholder Engagement Presentation Deck | 40 slides · Amazon
Shareholder letter Investor relations Beat · Market Size1 hit
12
This is a partial view of a larger table (items 6-10 shown).Amazon | Shareholder Engagement Presentation Deck | 40 slides · Amazon
Shareholder letter Investor relations Beat · Market Size1 hit
13
The slide focuses on ESG-related shareholder proposals and the company's defensive stance.Amazon | Shareholder Engagement Presentation Deck | 40 slides · Amazon
Shareholder letter Investor relations Beat · Market Size1 hit
14
This slide is part of a series of slides addressing shareholder proposals in a proxy statement context.Amazon | Shareholder Engagement Presentation Deck | 40 slides · Amazon
Shareholder letter Investor relations Beat · Market Size1 hit
15
The slide focuses on items 17, 18, and 19 specifically, despite the title referencing 6-23.Amazon | Shareholder Engagement Presentation Deck | 40 slides · Amazon
Shareholder letter Investor relations Beat · Market Size1 hit